Journey Medical Corporation
DERM
$7.69
$0.283.78%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 57.79M | 55.40M | 55.24M | 55.13M | 57.77M |
| Total Other Revenue | 1.61M | 1.00M | 1.00M | 1.00M | 0.00 |
| Total Revenue | 59.40M | 56.40M | 56.24M | 56.13M | 57.77M |
| Cost of Revenue | 17.72M | 16.44M | 17.23M | 18.44M | 18.45M |
| Gross Profit | 41.68M | 39.96M | 39.02M | 37.70M | 39.32M |
| SG&A Expenses | 44.57M | 43.91M | 42.35M | 40.20M | 39.99M |
| Depreciation & Amortization | 6.62M | 6.37M | 6.12M | 5.87M | 6.21M |
| Other Operating Expenses | -4.55M | -4.55M | -4.55M | -4.55M | -- |
| Total Operating Expenses | 64.89M | 63.26M | 63.15M | 69.81M | 75.79M |
| Operating Income | -5.50M | -6.86M | -6.91M | -13.68M | -18.02M |
| Income Before Tax | -8.54M | -8.62M | -8.24M | -14.61M | -18.21M |
| Income Tax Expenses | 121.00K | 121.00K | 61.00K | 61.00K | 126.00K |
| Earnings from Continuing Operations | -8.66 | -8.74 | -8.30 | -14.67 | -18.34 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -8.66M | -8.74M | -8.30M | -14.67M | -18.34M |
| EBIT | -5.50M | -6.86M | -6.91M | -13.68M | -18.02M |
| EBITDA | -1.32M | -2.94M | -3.24M | -10.25M | -14.76M |
| EPS Basic | -0.36 | -0.39 | -0.39 | -0.74 | -0.93 |
| Normalized Basic EPS | -0.22 | -0.27 | -0.28 | -0.50 | -0.61 |
| EPS Diluted | -0.37 | -0.39 | -0.40 | -0.75 | -0.93 |
| Normalized Diluted EPS | -0.22 | -0.27 | -0.28 | -0.50 | -0.61 |
| Average Basic Shares Outstanding | 92.17M | 87.75M | 84.45M | 81.60M | 78.98M |
| Average Diluted Shares Outstanding | 92.17M | 87.75M | 84.45M | 81.60M | 78.98M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |